How I treat mycosis fungoides and Sézary syndrome

HM Prince, S Whittaker… - Blood, The Journal of the …, 2009 - ashpublications.org
The most common subtypes of primary cutaneous T-cell lymphomas are mycosis fungoides
(MF) and Sézary syndrome (SS). The majority of patients have indolent disease; and given …

Biopsy-negative cardiac transplant rejection: etiology, diagnosis, and therapy

MC Fishbein, J Kobashigawa - Current opinion in cardiology, 2004 - journals.lww.com
Biopsy-negative cardiac transplant rejection: etiology, diag... : Current Opinion in Cardiology
Biopsy-negative cardiac transplant rejection: etiology, diagnosis, and therapy : Current Opinion …

[HTML][HTML] Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients

MG Bernengo, P Quaglino, A Comessatti… - …, 2007 - haematologica.org
Abstract Background and Objectives Alemtuzumab may be effective in Sézary syndrome
(SS), an aggressive cutaneous T-cell lymphoma, but is associated with severe hematologic …

New players in phototherapy: photopharmacology and bio-integrated optoelectronics

J Morstein, D Trauner - Current Opinion in Chemical Biology, 2019 - Elsevier
Photodynamic therapy and phototherapy are used in the clinic to treat dermatological
conditions, cancer, macular degeneration, and a variety of other diseases. Despite their long …

Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem …

N Apisarnthanarax, M Donato, M Körbling… - Bone marrow …, 2003 - nature.com
We conducted a retrospective analysis of all allogeneic stem cell transplantation (ASCT)
patients started on extracorporeal photopheresis (ECP) for the management of steroid …

[HTML][HTML] Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma

P Vieyra-Garcia, JD Crouch, JT O'Malley, EW Seger… - JCI insight, 2019 - ncbi.nlm.nih.gov
Psoralen plus UVA (PUVA) is an effective therapy for mycosis fungoides (MF), the skin-
limited variant of cutaneous T cell lymphoma (CTCL). In low-burden patients, PUVA reduced …

Evidence‐based practice of photopheresis 1987–2001: a report of a workshop of the British Photodermatology Group and the UK Skin Lymphoma Group

KE McKenna, S Whittaker, LE Rhodes, P Taylor… - 2006 - academic.oup.com
Photopheresis or extracorporeal photochemotherapy (ECP) is a novel immunomodulatory
therapy which involves separation of the patient's leucocyte‐rich plasma, followed by ex vivo …

Peripheral CD4+ CD25+ TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients

F Meloni, A Cascina, S Miserere, C Perotti… - Transplantation …, 2007 - Elsevier
Extracorporeal photopheresis (ECP) has been proposed as a possible alternative therapy
for patients with bronchiolitis obliterans syndrome (BOS), with some evidence of efficacy …

Skin cancer and immunosuppression

G Gerlini, P Romagnoli, N Pimpinelli - Critical reviews in oncology …, 2005 - Elsevier
All immunosuppressive treatments, either pharmacological or physical, have the potential to
impair the skin immune system network of cells and cytokines, thus leading to an increased …

[HTML][HTML] Pharmacological-and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults

GC Leitner, H Vogelsang - World journal of gastrointestinal …, 2016 - ncbi.nlm.nih.gov
Inflammatory bowel diseases (IBDs) are a group of chronic inflammatory conditions mainly
of the colon and small intestine. Crohn's disease (CD) and ulcerative colitis (UC) are the …